
October 17, 2022
Telerehabilitation for stroke and traumatic brain injury
One of the biggest changes emerging from the global pandemic is telemedicine. Using video calls to…
Disclaimers: NeuroAiD™ II is a trademark of Moleac. MLC601 and MLC901 are 2 different proprietary formulations which have been shown to be equivalent in pharmacology and are referred as NeuroAiD on this webpage.